Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3050 of 3284 entries
View as:

This Study Will Assess the Safety and Tolerability of AZD8418 After Single Increasing Oral Doses

Phase: N/A Priority: Normal
NCT ID: NCT01027234 Org: User:
Start: 11/30/09 End: 03/31/10 Due: 03/31/11

First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia

Phase: N/A Priority: Normal
NCT ID: NCT00322452 Org: User:
Start: 03/31/06 End: 06/30/10 Due: 06/30/11

Epidemiological Study to Describe Non-small-cell Lung Carcinoma (NSCLC) Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA

Phase: N/A Priority: Normal
NCT ID: NCT01330862 Org: User:
Start: 04/30/11 End: 03/31/13 Due: 03/31/14

Open-Label Absorption, Distribution, Metabolism, Excretion (ADME) and Pharmacokinetics (PK) Following a Single Oral Dose of AZD1236 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01007929 Org: User:
Start: 10/31/09 End: 11/30/09 Due: 11/30/10

Seroquel XR in Schizophrenia Relapse Prevention

Phase: N/A Priority: Normal
NCT ID: NCT00990626 Org: User:
Start: 10/31/09 End: 07/31/10 Due: 07/31/11

Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now

Phase: N/A Priority: Normal
NCT ID: NCT02835599 Org: User:
Start: 11/01/16 End: 04/06/17 Due: 04/06/18

Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236

Phase: N/A Priority: Normal
NCT ID: NCT00767052 Org: User:
Start: 09/30/08 End: 12/31/08 Due: 12/31/09

A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05775549 Org: User:
Start: 07/10/23 End: 10/27/23 Due: 10/27/24

Phase III Insulin Add-On Asia Regional Program - ST

Phase: N/A Priority: Normal
NCT ID: NCT02096705 Org: User:
Start: 03/31/14 End: 01/28/16 Due: 01/28/17

Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)

Phase: N/A Priority: Normal
NCT ID: NCT00163345 Org: User:
Start: 09/30/03 End: 05/31/06 Due: 05/31/07

Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)

Phase: N/A Priority: Normal
NCT ID: NCT00163319 Org: User:
Start: 11/30/04 End: 11/30/05 Due: 11/30/06

Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin Produc

Phase: N/A Priority: Normal
NCT ID: NCT01441869 Org: User:
Start: 10/31/11 End: 12/31/11 Due: 12/31/12

An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00419757 Org: User:
Start: 01/31/07 End: 06/30/08 Due: 06/30/09

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

Phase: N/A Priority: Normal
NCT ID: NCT00600496 Org: User:
Start: 12/14/07 End: 12/31/25 Due: 12/31/26

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Phase: N/A Priority: Normal
NCT ID: NCT05663515 Org: User:
Start: 09/30/24 End: 03/02/26 Due: 03/02/27

Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00536913 Org: User:
Start: 09/30/07 End: 02/29/08 Due: 02/28/09

A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.

Phase: N/A Priority: Normal
NCT ID: NCT06750276 Org: User:
Start: 12/06/24 End: 12/08/25 Due: 12/08/26

A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00502567 Org: User:
Start: 01/31/05 End: 06/30/11 Due: 06/30/12

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea

Phase: N/A Priority: Normal
NCT ID: NCT00039026 Org: User:
Start: 02/28/02 End: 08/31/03 Due: 08/31/04

Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)

Phase: N/A Priority: Normal
NCT ID: NCT03373045 Org: User:
Start: 02/27/18 End: 02/14/25 Due: 02/14/26

A Study to Investigate the Absolute Bioavailability, Absorption, Metabolism, Distribution and Excretion of [14C]AZD5363 (Capivasertib)

Phase: N/A Priority: Normal
NCT ID: NCT05419401 Org: User:
Start: 04/11/22 End: 07/12/22 Due: 07/12/23

Patterns of Care in Hormone-receptor Positive, Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01277926 Org: User:
Start: 04/30/11 End: 12/31/12 Due: 12/31/13

ALICIA (Acalabrutinib in CLL Therapy)

Phase: N/A Priority: Normal
NCT ID: NCT04746950 Org: User:
Start: 02/03/21 End: 12/31/25 Due: 12/31/26

Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00857584 Org: User:
Start: 05/31/09 End: 02/28/11 Due: 02/28/12

A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA

Phase: N/A Priority: Normal
NCT ID: NCT02258542 Org: User:
Start: 11/19/14 End: 07/02/18 Due: 07/02/19